stock

Gilead Sciences, Inc. (GILD)

0
September 3rd, 2020

Share

Stay up to date

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firms primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster, CA.

Financial Statements

Key Info

  • Industry: Biotechnology
  • Sector: Health Technology
  • CEO Name: Daniel P. O'Day

Key Statistics

  • Stock Price: $66.79
  • Dividend Yield: 3.9%
  • Market Capitalization: $83,735,958,800
  • Shares Outstanding: 1,253,720,000
  • Number of Employees: 11,800
  • Trailing 12-Month EPS: $-0.22
  • Trailing 12-Month DPS: $2.62
  • Payout Ratio: -1190.9%

Important Dates

  • Next Earnings Date: 2020-10-22
  • Next Ex-Dividend Date: 2020-06-11

Price Trends

  • Current Stock Price: $66.79
  • 52-week high: $85.97
  • 52-week low: $60.89
  • 200-day moving average: $71.58
  • 50-day moving average: $71.88

Performance

  • 1-Month Price Return: -6.9%
  • 3-Month Price Return: -10.2%
  • 6-Month Price Return: -10.0%
  • 1-Year Price Return: 6.1%
  • 2-Year Price Return: 6.7%
  • 5-Year Price Return: -37.9%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

September 3rd, 2020